This study is a parallel randomized controlled trial on 60 primiparous women with cesarean section pain, randomly divided into EFT and control groups. The study was approved by KTO Karatay University Faculty of Medicine Ethics Committee. Women will be included in the study according to the following criteria: at least primary school graduate, primiparous, planned cesarean section and 4 or more postoperative pain according to VAS. Women with chronic diseases such as heart disease, high blood pressure and diabetes, history of miscarriage, placenta previa, mental illness in the past year, psychoactive drug use, drug addiction, smoking, and pregnancy complications such as pre-eclampsia, bleeding, intrauterine death and preterm delivery will be excluded. Data collection will start in June 2025 and will be completed in August 2025.